Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.270
+0.020 (0.89%)
At close: Jul 14, 2025, 4:00 PM
2.221
-0.049 (-2.15%)
After-hours: Jul 14, 2025, 4:26 PM EDT

Stereotaxis Market Cap

Stereotaxis has a market cap or net worth of $196.03 million as of July 14, 2025. Its market cap has increased by 35.57% in one year.

Market Cap
196.03M
Enterprise Value
189.58M
1-Year Change
35.57%
Ranking
Category
Stock Price
$2.27

Market Cap Chart

Since August 12, 2004, Stereotaxis's market cap has increased from $183.10M to $196.03M, an increase of 7.06%. That is a compound annual growth rate of 0.33%.

History

DateMarket Cap% Change
Jul 11, 2025 193.50M 0.16%
Dec 31, 2024 193.20M 36.54%
Dec 29, 2023 141.50M -8.65%
Dec 30, 2022 154.90M -66.50%
Dec 31, 2021 462.40M 23.27%
Dec 31, 2020 375.10M 6.26%
Dec 31, 2019 353.00M 474.92%
Dec 31, 2018 61.40M 237.36%
Dec 29, 2017 18.20M 28.17%
Dec 30, 2016 14.20M -10.69%
Dec 31, 2015 15.90M -47.52%
Dec 31, 2014 30.30M -47.49%
Dec 31, 2013 57.70M 215.30%
Dec 31, 2012 18.30M -55.90%
Dec 30, 2011 41.50M -76.45%
Dec 31, 2010 176.20M -2.22%
Dec 31, 2009 180.20M 19.97%
Dec 31, 2008 150.20M -63.64%
Dec 31, 2007 413.10M 27.11%
Dec 29, 2006 325.00M 49.56%
Dec 30, 2005 217.30M 991.96%
Dec 31, 2004 19.90M -89.13%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 711.91B
Johnson & Johnson 377.51B
AbbVie 339.94B
Novo Nordisk 305.41B
UnitedHealth Group 275.86B
Novartis AG 236.71B
Abbott Laboratories 229.69B
AstraZeneca 218.74B
Market Cap Rankings